ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

Obituary: Edwin Fisher, NSABP Pathologist.

April 4, 2008

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988